Xvivo Perfusion Aktiebolag

Where the EU money came from

Funding by EU programme. Amounts are Xvivo Perfusion Aktiebolag's own share of each project, not the project's full budget.

Projects

3 EU-funded projects, newest first. Xvivo Perfusion Aktiebolag led 1 of them as coordinator. Each links to the official record.

• EXIT-CVDPartner

  EXIT-CVD

  Horizon Europe · 2026–2031 · Project on CORDIS ↗

  €42ktheir share
• LifeLUNGAssociated partner

  Improving Life expectancy of LUNG transplant recipients through innovative ex vivo perfusion gene therapy

  Horizon Europe · 2025–2029 · Project on CORDIS ↗
• BMEVLPCoordinator

  Biomarkers for clinical assessment of lungs intended for transplantation

  Horizon 2020 · 2014–2015 · Project on CORDIS ↗

  €50ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Katholieke Universiteit LeuvenBelgium · 2 shared projects
• Universitair Medisch Centrum UtrechtNetherlands · 2 shared projects
• Astrazeneca ABSweden · 2 shared projects
• University College LondonUnited Kingdom · 1 shared project
• Aarhus UniversitetDenmark · 1 shared project
• Universiteit UtrechtNetherlands · 1 shared project
• Politecnico di MilanoItaly · 1 shared project
• Technische Universiteit EindhovenNetherlands · 1 shared project
• Lunds UniversitetSweden · 1 shared project
• King'S College LondonUnited Kingdom · 1 shared project
• Institut National de Recherche Pour L'Agriculture, L'Alimentation et L'EnvironnementFrance · 1 shared project
• Eberhard Karls Universitaet TuebingenGermany · 1 shared project
• Universitat de BarcelonaSpain · 1 shared project
• Medizinische Universitaet WienAustria · 1 shared project
• Universitat BaselSwitzerland · 1 shared project
• Academisch Ziekenhuis GroningenNetherlands · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• cardiovascular diseases
• gene therapy
• mortality
• nano-materials
• physiology
• surgery
• transplantation